Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment

Lung Cancer ◽

10.1016/j.lungcan.2020.10.003 ◽

2020 ◽

Vol 150 ◽

pp. 90-96 ◽

Cited By ~ 1

Author(s):

Vivek Subbiah ◽

Luis Paz-Ares ◽

Benjamin Besse ◽

Victor Moreno ◽

Solange Peters ◽

...

Keyword(s):

Lung Cancer ◽

Antitumor Activity ◽

Cancer Patients ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

Oncology ◽

10.1159/000086974 ◽

2005 ◽

Vol 68 (4-6) ◽

pp. 350-355 ◽

Cited By ~ 5

Author(s):

Chih-Hsin Yang ◽

Min-Chun Chen ◽

Ann-Lii Cheng ◽

Chih-Hung Hsu ◽

Kun-Huei Yeh ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Survival Outcome ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Conventional Dose ◽

First Line Treatment

Download Full-text

Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases

Oncology Letters ◽

10.3892/ol.2016.5268 ◽

2016 ◽

Vol 12 (6) ◽

pp. 4635-4642 ◽

Cited By ~ 7

Author(s):

Dimitra Stefanou ◽

Sofia Stamatopoulou ◽

Antigoni Sakellaropoulou ◽

Gavriil Akakios ◽

Marina Gkiaouraki ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

MA14.06 Nintedanib-Docetaxel in 2nd Line Treatment in No Squamous Non-Small Cell Lung Cancer Patients, Refractory to First Line Treatment (GFPC02-15)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.614 ◽

2019 ◽

Vol 14 (10) ◽

pp. S306-S307

Author(s):

J.B. Auliac ◽

I. Monnet ◽

A. Bizieux ◽

L. Greillier ◽

L. Falchero ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece

Value in Health ◽

10.1016/j.jval.2011.08.1211 ◽

2011 ◽

Vol 14 (7) ◽

pp. A454 ◽

Cited By ~ 1

Author(s):

V. Fragoulakis ◽

A. Pallis ◽

G. Kourlaba ◽

V. Georgoulias ◽

N. Maniadakis

Keyword(s):

Lung Cancer ◽

Economic Evaluation ◽

Cancer Patients ◽

Egfr Mutation ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

PDL-1 Expression and Survival in Metastatic Non-Small Cell Lung Cancer Patients Who Received Chemotherapy as First- Line Treatment

10.5152/turkthoracj.2021.21151 ◽

2021 ◽

Author(s):

Pınar Gursoy ◽

◽

Burcu Çakar ◽

Damla Gunenc ◽

Deniz Nart ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Lung Cancer Targets and Therapy ◽

10.2147/lctt.s99303 ◽

2016 ◽

pp. 83 ◽

Cited By ~ 1

Author(s):

Marie Wislez ◽

Etienne Giroux-Leprieur ◽

Vincent Fallet ◽

Jacques Cadranel

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)

Lung Cancer ◽

10.1016/j.lungcan.2021.09.007 ◽

2021 ◽

Author(s):

Jean-Bernard Auliac ◽

Isabelle Monnet ◽

Acya Bizieux ◽

Laurent Greillier ◽

Margaux Geier ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Multicenter Phase

Download Full-text

The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: A meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2008.03.001 ◽

2008 ◽

Vol 62 (2) ◽

pp. 242-252 ◽

Cited By ~ 6

Author(s):

Chia-Hsuin Chang ◽

Kuan-Yu Chen ◽

Yinong Young-Xu ◽

Tobias Kurth ◽

E. John Orav ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Meta Analysis ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Safety And Efficacy ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor

ESMO Open ◽

10.1016/j.esmoop.2021.100279 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100279

Author(s):

R. Serna-Blasco ◽

E. Sánchez-Herrero ◽

S. Sanz-Moreno ◽

A. Rodriguez-Festa ◽

E. García-Veros ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

First Line Treatment

Download Full-text

Evaluation Of Survival Outcomes In Select First-Line Treatment Regimens For Advanced Nonsquamous Non-Small Cell Lung Cancer Patients

Value in Health ◽

10.1016/j.jval.2013.03.005 ◽

2013 ◽

Vol 16 (3) ◽

pp. A1

Author(s):

M. Bhor ◽

K.B. Winfree ◽

K. Sail ◽

A. Zagar ◽

G. Pohl ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Survival Outcomes ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Treatment Regimens ◽

First Line Treatment

Download Full-text